Supplementary Figure 1 from An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement <i>In Vivo</i>

Stefan Lohse,Saskia Meyer,Laura A.P.M. Meulenbroek,J.H. Marco Jansen, Maaike Nederend, Anna Kretschmer,Katja Klausz, Uwe Möginger,Stefanie Derer,Thies Rösner,Christian Kellner,Denis Schewe,Peter Sondermann,Sanjay Tiwari,Daniel Kolarich,Matthias Peipp,Jeanette H.W. Leusen,Thomas Valerius

crossref（2023）

引用 0|浏览3

暂无评分

摘要

SDS-PAGE separated and electroblotted IgA Proteins after staining with direct blue 71. The red boxes indicate the bands cut out for subsequent N-glycan Analysis.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Supplementary Figure 1 from An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement &lt;i&gt;In Vivo&lt;/i&gt;

Supplementary Figure 1 from An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement <i>In Vivo</i>